Zalcitabine is a nucleoside analog reverse-transcriptase inhibitor primarily used in the management of human immunodeficiency virus (HIV-1) infections to suppress viral replication. This category comprises… Read more
Zalcitabine is a nucleoside analog reverse-transcriptase inhibitor primarily used in the management of human immunodeficiency virus (HIV-1) infections to suppress viral replication. This category comprises the active pharmaceutical ingredient alongside critical reference materials, including metabolites like zalcitabine monophosphate and zalcitabine triphosphate, as well as process-related impurities such as zalcitabine related compound A. Pharmaceutical laboratories rely on these high-quality standards to support rigorous impurity profiling, method validation, and stability testing. By utilizing these precise compounds, researchers and quality control analysts can ensure the accuracy of their analytical procedures, verify drug purity, and monitor metabolic pathways during development. These materials, including stable isotope-labelled standards, serve as essential tools for laboratories maintaining strict adherence to regulatory requirements and ensuring the safety and efficacy of therapeutic regimens involving this nucleoside analog.